4//SEC Filing
Dachille Douglas A. 4
Accession 0000899243-22-001169
CIK 0001743881other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:06 PM ET
Size
6.8 KB
Accession
0000899243-22-001169
Insider Transaction Report
Form 4
Dachille Douglas A.
Director
Transactions
- Purchase
Common Stock
2022-01-04$16.82/sh+5,000$84,100→ 5,000 total(indirect: By Trust) - Purchase
Common Stock
2022-01-05$15.91/sh+5,000$79,550→ 10,000 total(indirect: By Trust)
Footnotes (1)
- [F1]These shares are owned directly by The Dachille 2012-1 Family Trust for the benefit of the reporting person's children, for which the reporting person's spouse is the trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0001652908
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:06 PM ET
- Size
- 6.8 KB